Journal of the International AIDS Society

Papers
(The H4-Index of Journal of the International AIDS Society is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Issue Information923415346
Effect of differentiated direct‐to‐pharmacy PrEP refill visits supported with client HIV self‐testing on clinic visit time and early PrEP continuation758133037
Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in t137
Challenges posed by COVID‐19 to people who inject drugs and lessons from other outbreaks112
The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study111
National trends in HIV pre‐exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017102
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment99
Lessons learned from HIV can inform our approach to COVID‐19 stigma86
The time is now: expedited HIV differentiated service delivery during the COVID‐19 pandemic67
Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub‐Saharan Africa: a rapid systematic review66
Weight gain before and after switch from TDF to TAF in a U.S. cohort study65
COVID‐19, HIV and key populations: cross‐cutting issues and the need for population‐specific responses53
New pathogen, same disparities: why COVID‐19 and HIV remain prevalent in U.S. communities of colour and implications for ending the HIV epidemic51
Acceleration of differentiated service delivery for HIV treatment in sub‐Saharan Africa during COVID‐1949
SARS‐CoV‐2 and HIV coinfection: clinical experience from Rhode Island, United States49
Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial47
Preferences for long‐acting Pre‐Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment46
Multiple forms of discrimination and internalized stigma compromise retention in HIV care among adolescents: findings from a South African cohort44
PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa42
Preventing mental health conditions in adolescents living with HIV: an urgent need for evidence40
Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial40
Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study39
Missed opportunities to prevent HIV infections among pre‐exposure prophylaxis users: a population‐based mixed methods study, San Francisco, United States39
Antiretroviral treatment interruption among people living with HIV during COVID‐19 outbreak in China: a nationwide cross‐sectional study39
Increasing awareness of HIV pre‐exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta‐analysis of global data38
Treating depression and improving adherence in HIV care with task‐shared cognitive behavioural therapy in Khayelitsha, South Africa: a randomized controlled trial38
Scaling up peer‐led community‐based differentiated support for adolescents living with HIV: keeping the needs of youth peer supporters in mind to sustain success37
Early pre‐exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa36
Prevalence and factors associated with common mental disorders in young people living with HIV in sub‐Saharan Africa: a systematic review36
Gendered health institutions: examining the organization of health services and men’s use of HIV testing in Malawi35
Current approaches to HIV vaccine development: a narrative review34
“I just believe there is a risk” understanding of undetectable equals untransmissible (U = U) among health providers and HIV‐negative partners in serodiscordant relationships in Kenya34
Index and targeted community‐based testing to optimize HIV case finding and ART linkage among men in Zambia33
0.053343057632446